PsoProtect Registry Data Update
PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data
Wednesday, June 15, 2022
International Psoriasis Council
Menu
Advancing Knowledge. Enhancing Care.
Menu
COVID-19 & Psoriasis Resource Center
To assist dermatologists and the patients they serve, the IPC is collecting information from around the world on coronavirus and psoriasis. If you have a resource on COVID-19 and psoriasis to add, please submit it to IPC.
Latest News on COVID-19 & Psoriasis
Commentary: Vaccine Hesitancy and Access to Psoriasis Care in the COVID-19 Pandemic
The COVID-19 pandemic has been a significant concern, and vaccination has been crucial worldwide in its combat.
Wednesday, May 11, 2022
Commentary: Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
A research group led by Catherine Smith from St John’s Institute of Dermatology described humoral and cellular immunity.
Tuesday, January 25, 2022
IPC Resources
IPC Statements on COVID-19 & Psoriasis
Read statements from IPC’s Board of Directors based on the current understanding of the impact of COVID-19 and psoriasis.
Commentaries
Psoriasis experts worldwide give their take on the most important COVID-19 publications.
Treatment Guidelines
Information from around the world on psoriasis and the coronavirus to assist dermatologists and the patients they serve.
Videos
Videos on current research and treatment strategies regarding psoriasis and COVID-19 from IPC congress symposia and webinars presented by IPC experts.
Research
PsoProtect International Registry
PsoProtect is an international registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. The registry seeks to improve our understanding of how factors such as immunomodulator therapies and comorbidities impact outcomes to COVID-19 in psoriasis. This information will inform clinicians when assessing risk and treating COVID-19 in patients with psoriasis.